Leo Sher, M.D. Our research report, “Clinical features and psychiatric comorbidities in military veterans with schizophrenia with or without suicidality” is published in the November 2021 issue of the Journal of Psychiatric Research (1). There is a need to increase our understanding of what elevates suicide risk in veterans with schizophrenia as a first step […]
Leo Sher, M.D. Our research report, “Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior” was published in the October 2011 issue of the American Journal of Psychiatry (1). In our double-blind, randomized, parallel-group study, we tested the hypothesis that lithium offers bipolar […]
Leo Sher, M.D. A research article, “Changes in suicide mortality of Hungary during the first year of the COVID-19 pandemic” has been published in Orvosi Hetilap, a Hungarian medical journal (1). The authors compared the observed number of suicides during the COVID-19 pandemic in March–December 2020 with the expected numbers which were calculated based on […]
Leo Sher, M.D. American scientists David Julius and Ardem Patapoutian were awarded the 2021 Nobel Prize in Physiology or Medicine for their discoveries of receptors for temperature and touch (1). The Nobel Committee states that “David Julius utilized capsaicin, a pungent compound from chili peppers that induces a burning sensation, to identify a sensor in […]
Leo Sher, M.D. Our research work, “A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder” was published 15 years ago in the October 2006 issue of Bipolar Disorders (1). We examined the relation between CSF 5-hydroxyindolacetic acid (5-HIAA), homovanillic acid (HVA), and […]
Leo Sher, M.D. The Office of Mental Health and Suicide Prevention of the U.S. Department of Veterans Affairs recently published the 2021 National Veteran Suicide Prevention Annual Report (1). This report provides information from 2001 through 2019, while recent prior reports included data from 2005 forward. Also, this report includes the most current data and […]
Gurpreet Singh Guliani, M.D., Steven Lippmann, M.D. We have been hearing a lot about ivermectin these days. You too? Well, ivermectin has long been established as a veterinary medication to treat animals with many different types of parasitic infections; useful there, it has been around for a while without fanfare. Ivermectin is also approved for […]
Aya Allam, M.D., Steven Lippmann, M.D. Now in our second year of a coronavirus pandemic, the Food and Drug Administration (FDA) is approving COVID-19 vaccines. They are well researched, proven safe, currently effective, and already utilized by millions of people. Trust in the FDA as a medical authority enhances their recommendations for getting immunized. Similarly, […]
Leo Sher, M.D. Our research paper, “Early response to light therapy partially predicts long-term antidepressant effects in patients with seasonal affective disorder” was published 20 years ago in the September 2001 issue of the Journal of Psychiatry and Neuroscience (1). The aim of the study was to determine if the antidepressant effect of 1 hour […]
Shivam Gulati, M.D., Steven Lippmann, M.D. Introduction Post-COVID-19 syndrome includes illness presentations during or following an infection that persist longer than 12 weeks and not otherwise diagnosed (1). Manifestation of this so-called “long-covid” can exist throughout the body, including the nervous system. Psychological aspects are often the first symptoms, sometimes even before recognizing COVID-19 disease. […]
